Iveda Solutions Inc美股招股说明书(2026-04-02版)

Prospectus Supplement No. 14(To Prospectus effective March 31, 2022) 235,625 Shares of Common StockWarrants to Purchase up to 235,625 Shares of Common Stock This Prospectus Supplement supplements and amends the Prospectus dated March 28, 2022 and effective March 31, 2022(the “Prospectus”), relating to the warrants to purchase 235,625 shares at $34.00 per share of common stock of Iveda Solutions, Inc.(the “Company”) by the stockholders identified in the Prospectus. This Prospectus Supplement is being filed to include the information set forth in our Annual Report on Form 10-K for theperiod ended December 31, 2025, filed by the Company with the Securities and Exchange Commission on March 31, 2026 (the “Form10-K”). The Form 10-K is attached hereto. This Prospectus Supplement is not complete without and may not be delivered or utilized except in connection with theProspectus, including any supplements and amendments thereto. This Prospectus Supplement should be read in conjunction with theProspectus, which is to be delivered with this Prospectus Supplement. This Prospectus Supplement is qualified by reference to theProspectus, except to the extent that the information in this Prospectus Supplement updates or supersedes the information contained inthe Prospectus, including any supplements and amendments thereto. See “Risk Factors” beginning on page 6 of the Prospectus to read about factors you should consider before buyingshares of our common stock. Neither the Securities and Exchange Commission nor any other regulatory body has approved or disapproved of thesesecurities or passed upon the accuracy or adequacy of the Prospectus. Any representation to the contrary is a criminal offense. The date of this Prospectus Supplement is April 1, 2026